Int J Antimicrob Agents 2008, 32:130–138.PubMedCrossRef 40. Deslouches B, Phadke SM, see more Lazarevic V, Cascio M, Islam K, Montelaro RC, et al.: De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother 2005, 49:316–322.PubMedCrossRef 41. Wu M, Hancock RE: Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 1999, 274:29–35.PubMedCrossRef 42. Phadke SM, Lazarevic V, Bahr CC, Islam K, Stolz DB,

Watkins S, et al.: Lentivirus lytic peptide 1 perturbs both outer and inner membranes of VX-661 ic50 Serratia marcescens. Antimicrob Agents Chemother 2002, 46:2041–2045.PubMedCrossRef 43. Loit E, Hincke MT, Altosaar I: Synthetic antimicrobial peptide L8 (MHLHKTSRVTLYLL) has membrane permeabilisation and bacterial aggregation activity. Int J Antimicrob Agents 2010, 35:410–411.PubMedCrossRef 44. Harms JM, Bartels H, Schlunzen F, Yonath A: Antibiotics acting on the translational machinery. J Cell Sci

2003, 116:1391–1393.PubMedCrossRef 45. Schmitz FJ, Higgins PG, Mayer S, Fluit AC, Dalhoff A: Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur Smad inhibitor J Clin Microbiol Infect Dis 2002, 21:647–659.PubMedCrossRef 46. Reynolds PE: Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 1989, 8:943–950.PubMedCrossRef 47. Tsang JC, Weber DA, Brown DA: Evidences for complex formation between polymyxin B and lipopolysaccharides from Serratia marcescens. J Antibiot (Tokyo) 1976, 29:735–742. 48. Hancock RE: The bacterial outer membrane as a drug barrier. Trends Microbiol 1997, 5:37–42.PubMedCrossRef 49. Epand RM, Epand RF: Bacterial membrane lipids in the action of antimicrobial agents. J Pept Sci

2010. 50. Hancock RE, Chapple DS: Peptide antibiotics. Antimicrob Agents Chemother 1999, 43:1317–1323.PubMed 51. Bechinger B: The structure, mafosfamide dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochim Biophys Acta 1999, 1462:157–183.PubMedCrossRef 52. Koo SP, Yeaman MR, Nast CC, Bayer AS: The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. Infect Immun 1997, 65:4795–4800.PubMed 53. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, et al.: Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 2010, 328:1168–1172.PubMedCrossRef 54. Casteels P, Tempst P: Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. Biochem Biophys Res Commun 1994, 199:339–345.PubMedCrossRef 55. Zaknoon F, Sarig H, Rotem S, Livne L, Ivankin A, Gidalevitz D, et al.: Antibacterial properties and mode of action of a short acyl-lysyl oligomer. Antimicrob Agents Chemother 2009, 53:3422–3429.